Name: Cannabis Market by Compound Type (THC-dominant, CBD-dominant, Balanced THC & CBD), Product Type (Flowers/Buds, Oil/Tinctures, Edibles, Topicals, Other Product Types), Application (Medical Use, Recreational Use, Industrial Use, Nutraceutical & Wellness Use, Cosmetics & Personal Care Use), Source (Hemp, Marijuana) and Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: FB6762
Price: 4950 USD
Availability: InStock

報告摘要

The global market for cannabis is estimated to be valued at USD 72.83 billion in 2025 and is projected to reach USD 125.76 billion by 2030, at a CAGR of 11.5% during the forecast period. The increasing demand for medical cannabis is a major market driver. As clinical research continues to validate the therapeutic potential of cannabinoids like THC and CBD, more countries and states are legalizing medical cannabis for conditions such as chronic pain, epilepsy, multiple sclerosis, anxiety, and sleep disorders. This has led to a growing patient base actively seeking plant-based, natural alternatives to traditional pharmaceuticals. Additionally, advancements in product formulations such as oils, capsules, edibles, and topicals are making cannabis-based treatments more accessible, discreet, and easy to administer. Regulatory agencies in various regions are also expanding medical cannabis programs, encouraging the development of pharmaceutical-grade products with standardized dosing and safety profiles. Rising consumer awareness about the health benefits of medical cannabis, combined with supportive government policies and increased clinical adoption, is further accelerating market demand, creating new opportunities for producers, distributors, and healthcare providers worldwide. “The industrial use segment is expected to be the second-fastest-growing application in the cannabis market.” Industrial applications include textiles, with hemp being a key component. Textile-use cannabis refers to cultivating industrial hemp, a type of cannabis plant grown specifically for its strong, durable fibers rather than its psychoactive compounds. Hemp fibers are valued for their sustainability, strength, and versatility in textiles. They are commonly used to create fabrics, ropes, twines, carpets, insulation, upholstery, canvas, and eco-friendly clothing. Known for being lightweight, breathable, and resistant to pests and UV rays, hemp textiles are also biodegradable and require less water and chemicals than cotton. As demand for sustainable materials grows, hemp-based textiles are increasingly preferred in fashion, home decor, and industrial fabric applications. “The marijuana segment holds the largest share of the cannabis market, by source.” Marijuana refers to the dried flowers, leaves, stems, and seeds of the cannabis plant that contain psychoactive compounds, mainly tetrahydrocannabinol (THC). It is used in various forms, including dried flowers (for smoking or vaping), edibles, oils, tinctures, topicals, and concentrates. Its uses range from recreational purposes, such as relaxation and euphoria, to medical treatments for chronic pain, epilepsy, anxiety, and nausea. In March 2025, Aurora Cannabis Inc. announced a breakthrough in plant genetics, developing a powdery mildew-resistant marijuana strain through its Aurora Coast R&D program, which improves crop health, yield, and reliability for both recreational and medical marijuana cultivation. Asia Pacific holds a significant market share in the global cannabis market. The Asia Pacific cannabis market is gaining momentum, driven by increased awareness of medical cannabis benefits, evolving regulatory frameworks, and growing demand for plant-based wellness options. Countries like Thailand, Australia, and New Zealand have legalized medical cannabis, while others, such as Japan and South Korea, have allowed limited therapeutic use under strict regulations. The region’s expanding senior population and increasing cases of chronic conditions like cancer and arthritis are further boosting demand for cannabis-based treatments. Additionally, interest in hemp-based textiles, food, and cosmetics is growing. A notable development occurred in April 2025, when Tilray introduced Good Supply medical cannabis pastilles in Australia, marking its strategic entry into the country’s growing medical cannabis market. In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the cannabis market: • By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30% • By Designation: Directors– 20%, Managers – 50%, Executives- 30% • By Region: North America – 25%, Europe – 30%, Asia Pacific – 20%, South America – 15% and Rest of the World –10% Prominent companies in the market include Canopy Growth Corporation (Canada), Curaleaf (US), Cresco Labs (US), Green Thumb Industries (GTI) (US), Tilray Brands (US), Aurora Cannabis Inc. (Canada), Trulieve (US), MedMen (US), Blüm Holdings Inc. (US), Organigram Global (Canada), TerrAscend (US), Village Farms International Inc. (US), Verano (US), The Cronos Group (Canada), and Medical Marijuana, Inc. (US). Other players include Vivo Cannabis Inc. (Canada), Ecofibre (Australia), Tikun Olam (Israel), Maricann Inc. (Canada), Satipharm (Canada), CannaBliss Organic LLC (US), Connected Cannabis Co. (US), Justice Cannabis Co. (US), Heritage Holding of California, LLC (US), Somai Pharmaceuticals (Portugal). Research Coverage: This research report categorizes the cannabis market by compound (THC-dominant, CBD-dominant, balanced THC & CBD), product type (flowers/buds, oil/tinctures, edibles, topicals, other products), application (medical use, recreational use, industrial use, nutraceutical & wellness use, cosmetics & personal care), source (hemp, marijuana), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information about major factors such as drivers, restraints, challenges, and opportunities influencing the growth of the cannabis market. A thorough analysis of key industry players provides insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments related to the cannabis market. Competitive analysis of upcoming startups in the cannabis ecosystem is included. Additionally, industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes are also covered in this study. Reasons to buy this report: The report will assist market leaders and new entrants by providing estimates of revenue figures for the overall cannabis market and its subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market's pulse and offers information on key drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (increasing cannabis demand for medicinal applications), restraints (complex regulatory structure for cannabis usage), opportunities (inorganic growth strategies adopted by US cannabis companies), and challenges (intensive water consumption and inability to maintain consistency during cannabis cultivation) • New service launch/innovation: Detailed insights on R&D activities and service launches in the cannabis market • Market Development: Comprehensive information about lucrative markets—the report analyzes the cannabis market across varied regions • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cannabis market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparisons, and product footprints of leading players such as Canopy Growth Corporation (Canada), Curaleaf (US), Cresco Labs (US), Green Thumb Industries (GTI) (US), Tilray Brands (US), and others in the cannabis market

目錄 Table of Contents

1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 CANNABIS MARKET SEGMENTATION AND REGIONAL SCOPE 28 1.3.2 YEARS CONSIDERED 29 1.3.3 CURRENCY CONSIDERED 30 1.4 VOLUME UNIT 30 1.5 STAKEHOLDERS 30 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 2.1.1 SECONDARY DATA 33 2.1.1.1 Key data from secondary sources 33 2.1.2 PRIMARY DATA 33 2.1.2.1 Key data from primary sources 34 2.1.2.2 Key industry insights 34 2.1.2.3 Breakdown of primary interviews 35 2.2 MARKET SIZE ESTIMATION 35 2.2.1 BOTTOM-UP APPROACH 36 2.2.2 TOP-DOWN APPROACH 37 2.3 DATA TRIANGULATION 38 2.4 RESEARCH ASSUMPTIONS 39 2.5 RESEARCH LIMITATIONS 39 2.6 RISK ASSESSMENT 39 2.7 FACTOR ANALYSIS 40 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 46 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CANNABIS MARKET 46 4.2 CANNABIS MARKET, BY COUNTRY 47 4.3 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE AND COUNTRY 47 4.4 CANNABIS MARKET, BY SOURCE 48 4.5 CANNABIS MARKET, BY COMPOUND TYPE 49 4.6 CANNABIS MARKET, BY APPLICATION 49 4.7 CANNABIS MARKET, BY PRODUCT TYPE 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MACROECONOMIC OUTLOOK 51 5.2.1 INCREASE IN CANNABIS PRODUCTION 51 5.2.2 RISING ANXIETY IN US ADULT POPULATION 52 5.3 MARKET DYNAMICS 54 5.3.1 DRIVERS 54 5.3.1.1 Increasing cannabis demand for medicinal applications 54 5.3.1.2 Legalization & regulatory support 55 5.3.1.3 Advancing R&D and technology as catalysts for cannabis industry growth 58 5.3.1.4 Rising global cannabis sales helping online retailers expand 59 5.3.1.5 Shift toward natural & plant-based products 60 5.3.2 RESTRAINTS 60 5.3.2.1 Regulatory complexity and lack of uniform product standards 60 5.3.2.2 Illicit market competition in California 61 5.3.2.3 Overcoming persistent social stigma and negative perceptions 61 5.3.3 OPPORTUNITIES 62 5.3.3.1 Building cannabis tourism and lifestyle experiences 62 5.3.3.2 Focus on pet wellness and veterinary cannabis 63 5.3.3.3 Rising emphasis on inorganic growth and strong potential for advancement 63 5.3.4 CHALLENGES 64 5.3.4.1 Building consumer education and awareness 64 5.3.4.2 Hiring and retaining skilled workforce 64 5.3.4.3 High water usage and challenges in achieving consistent quality 65 5.3.4.4 Advertising and marketing restrictions 65 5.4 IMPACT OF GEN AI ON CANNABIS MARKET 66 5.4.1 INTRODUCTION 66 5.4.2 CASE STUDY ANALYSIS 68 5.4.2.1 Tilray leverages digital platforms and AI-driven insights to optimize product innovation and consumer engagement 68 5.4.3 IMPACT ANALYSIS: CANNABIS MARKET 68 5.4.4 ADJACENT ECOSYSTEMS USING GENERATIVE AI 68 6 INDUSTRY TRENDS 70 6.1 INTRODUCTION 70 6.2 SUPPLY CHAIN ANALYSIS 70 6.3 VALUE CHAIN ANALYSIS 71 6.3.1 RESEARCH AND DEVELOPMENT (R&D) 72 6.3.2 RAW MATERIAL SOURCING 72 6.3.3 PRODUCTION 72 6.3.4 PACKAGING & STORAGE 72 6.3.5 DISTRIBUTION & RETAIL QUALITY CHECKS 72 6.3.6 CONSUMER FEEDBACK & REGULATORY SURVEILLANCE 73 6.4 TRADE ANALYSIS 73 6.4.1 EXPORT DATA FOR HS CODE 530210 73 6.4.2 IMPORT DATA FOR HS CODE 530210 75 6.5 TECHNOLOGY ANALYSIS 77 6.5.1 KEY TECHNOLOGIES 77 6.5.1.1 Led Glow Light 77 6.5.1.2 Nanoencapsulation 77 6.5.1.3 Artificial Intelligence and Blockchain 78 6.5.2 COMPLEMENTARY TECHNOLOGIES 78 6.5.2.1 Crop Steering 78 6.5.2.2 Vertical Farming 79 6.5.2.3 Innovative Hardware Tech Devices 79 6.5.3 ADJACENT TECHNOLOGIES 80 6.5.3.1 IOT Automation 80 6.5.3.2 Genetic Engineering 81 6.6 PRICING ANALYSIS 81 6.6.1 INDICATIVE SELLING PRICE TREND, BY KEY PLAYER 81 6.6.2 INDICATIVE SELLING PRICE TREND, BY SOURCE 82 6.6.3 INDICATIVE SELLING PRICE TREND, BY REGION 82 6.7 ECOSYSTEM ANALYSIS 83 6.7.1 SUPPLY SIDE 83 6.7.2 DEMAND SIDE 83 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85 6.9 PATENT ANALYSIS 86 6.10 KEY CONFERENCES AND EVENTS, 2025–2026 91 6.11 TARIFFS AND REGULATORY LANDSCAPE 91 6.11.1 TARIFFS RELATED TO INDUSTRIAL CANNABIS 91 6.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 6.11.3 REGULATORY FRAMEWORK 94 6.11.3.1 North America 94 6.11.3.1.1 US 94 6.11.3.1.2 Canada 95 6.11.3.1.3 Mexico 96 6.11.3.2 Europe 97 6.11.3.2.1 UK 97 6.11.3.2.2 Germany 97 6.11.3.3 Asia Pacific 98 6.11.3.3.1 China 98 6.11.3.3.2 India 98 6.11.3.4 South America 99 6.11.3.4.1 Brazil 99 6.11.3.5 Rest of the World 99 6.11.3.5.1 South Africa 99 6.12 IMPACT OF 2025 US TARIFFS—CANNABIS MARKET 100 6.12.1 INTRODUCTION 100 6.12.2 KEY TARIFF RATES 100 6.12.3 DISRUPTIONS IN CANNABIS PRODUCTS 101 6.12.4 PRICE IMPACT ANALYSIS 102 6.12.5 IMPACT ON COUNTRIES/REGIONS 103 6.12.5.1 US 103 6.12.5.2 Europe 103 6.12.5.3 China 104 6.12.6 IMPACT ON END-USE INDUSTRIES 104 6.13 PORTER’S FIVE FORCES ANALYSIS 105 6.13.1 THREAT OF NEW ENTRANTS 106 6.13.2 THREAT OF SUBSTITUTES 106 6.13.3 BARGAINING POWER OF SUPPLIERS 107 6.13.4 BARGAINING POWER OF BUYERS 107 6.13.5 INTENSITY OF COMPETITIVE RIVALRY 107 6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 108 6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 108 6.14.2 BUYING CRITERIA 109 6.15 CASE STUDY ANALYSIS 110 6.15.1 CASE STUDY 1: AURORA’S STRATEGIC ENTRY INTO INDUSTRIAL HEMP 110 6.15.2 CASE STUDY 2: TILRAY BUILDS GERMAN MEDICAL CANNABIS SUPPLY CHAIN 110 6.15.3 CASE STUDY 3: DEMECAN LAUNCHES LIVE ROSIN UNDER GOOD MANUFACTURING PRACTICE (GMP) 110 6.16 INVESTMENT AND FUNDING SCENARIO 111 7 CANNABIS MARKET, BY COMPOUND TYPE 112 7.1 INTRODUCTION 113 7.2 THC-DOMINANT 114 7.2.1 INCREASING LEGALIZATION OF RECREATIONAL CANNABIS PROPELS THC-DOMINANT CANNABIS MARKET 114 7.3 CBD-DOMINANT 115 7.3.1 INCREASED POPULARITY OF CBD EDIBLES TO DRIVE CBD-DOMINANT CANNABIS PRODUCTS MARKET 115 7.4 BALANCED THC & CBD 116 7.4.1 BALANCED THC & CBD STRAINS WITNESS GROWTH AS CBD DIMINISHES PSYCHOACTIVE PROPERTIES OF THC 116 8 CANNABIS MARKET, BY PRODUCT TYPE 118 8.1 INTRODUCTION 119 8.2 FLOWERS/BUDS 120 8.2.1 AUTOMATION AND SUSTAINABLE PACKAGING TO BE KEY TRENDS IN PRE ROLL DOMAIN 120 8.3 OILS/TINCTURES 122 8.3.1 PARTNERSHIPS AND EXPANSION OF CANNABIS OILS TO DRIVE MARKET 122 8.4 EDIBLES 123 8.4.1 RISING INTEREST OF FOOD & BEVERAGE COMPANIES IN CANNABIS-INFUSED EDIBLES TO DRIVE MARKET 123 8.5 TOPICALS 125 8.5.1 TOPICALS WITNESSING INCREASED DEMAND IN SKINCARE INDUSTRY 125 8.6 OTHER PRODUCT TYPES 126 9 CANNABIS MARKET, BY APPLICATION 128 9.1 INTRODUCTION 129 9.2 MEDICINAL USE 130 9.2.1 RISING USE IN TREATMENT DRIVES DEMAND FOR MEDICAL CANNABIS 130 9.2.1.1 Pain management 131 9.2.1.2 Neurological health management 131 9.2.1.3 Mental health management 131 9.2.1.4 Other medical purposes 131 9.3 RECREATIONAL USE 132 9.3.1 WIDER LEGALIZATION STATUS OF RECREATIONAL CANNABIS TO BOOST MARKET GROWTH 132 9.4 INDUSTRIAL USE 134 9.4.1 EXPANDING INDUSTRIAL APPLICATIONS AND SUSTAINABLE POTENTIAL OF CANNABIS TO DRIVE MARKET 134 9.4.1.1 Textiles 135 9.4.1.2 Paper 135 9.4.1.3 Food & beverages 136 9.4.1.4 Biodegradable materials 136 9.5 NUTRACEUTICAL & WELLNESS USE 137 9.5.1 GROWTH IN CBD-INFUSED NUTRACEUTICALS AND WELLNESS PRODUCTS TO DRIVE MARKET 137 9.6 COSMETIC & PERSONAL CARE USE 139 9.6.1 EXPANDING APPLICATIONS OF CBD-INFUSED SKINCARE AND PERSONAL CARE PRODUCTS TO DRIVE MARKET 139 10 CANNABIS MARKET, BY SOURCE 141 10.1 INTRODUCTION 142 10.2 HEMP 143 10.2.1 EXPANDING INDUSTRIAL APPLICATIONS AND WELLNESS INNOVATIONS TO DRIVE HEMP MARKET 143 10.3 MARIJUANA 144 10.3.1 DIVERSIFICATION OF MARIJUANA APPLICATIONS TO DRIVE MARKET 144 11 CANNABIS MARKET, BY REGION 147 11.1 INTRODUCTION 148 11.2 NORTH AMERICA 150 11.2.1 US 154 11.2.1.1 Technological advancements & precision cultivation to drive market 154 11.2.2 CANADA 155 11.2.2.1 Strong presence of leading market players to fuel growth 155 11.2.3 MEXICO 156 11.2.3.1 Emerging domestic brands and startups to propel market 156 11.3 EUROPE 157 11.3.1 GERMANY 162 11.3.1.1 Increased physician willingness to prescribe medical cannabis drives market growth 162 11.3.2 UK 163 11.3.2.1 Growing investment and M&A activities driving the market 163 11.3.3 FRANCE 164 11.3.3.1 Government reimbursement and structured healthcare integration to support growth 164 11.3.4 SPAIN 165 11.3.4.1 Favorable climate and infrastructure for low-cost cultivation driving market 165 11.3.5 ITALY 166 11.3.5.1 Expansion of authorized pharmacies for medical cannabis distribution to drive market 166 11.3.6 REST OF EUROPE 167 11.4 ASIA PACIFIC 168 11.4.1 CHINA 171 11.4.1.1 Strong focus on industrial hemp production to strengthen growth prospects 171 11.4.2 INDIA 172 11.4.2.1 Rising domestic demand for natural and plant-based remedies to drive market 172 11.4.3 JAPAN 173 11.4.3.1 Public and institutional support for industrial hemp driving market growth 173 11.4.4 AUSTRALIA & NEW ZEALAND 174 11.4.4.1 Rising investment from global cannabis companies to drive market 174 11.4.5 THAILAND 175 11.4.5.1 Growing wellness and cannabis tourism sector to fuel market growth 175 11.4.6 REST OF ASIA PACIFIC 176 11.5 SOUTH AMERICA 177 11.5.1 BRAZIL 180 11.5.1.1 Strengthening domestic innovation and strategic partnerships to drive market 180 11.5.2 ARGENTINA 181 11.5.2.1 Establishment of ARICCAME and regulatory realignment to support market growth 181 11.5.3 REST OF SOUTH AMERICA 182 11.6 REST OF THE WORLD 183 11.6.1 MIDDLE EAST 186 11.6.1.1 Evolving public perception and patient advocacy driving the market 186 11.6.2 AFRICA 187 11.6.2.1 Development of cannabis research and innovation to drive market 187 12 COMPETITIVE LANDSCAPE 189 12.1 OVERVIEW 189 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 190 12.3 REVENUE ANALYSIS, 2019–2023 192 12.4 MARKET SHARE ANALYSIS, 2024 192 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 195 12.5.1 STARS 195 12.5.2 EMERGING LEADERS 196 12.5.3 PERVASIVE PLAYERS 196 12.5.4 PARTICIPANTS 196 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 197 12.5.5.1 Company footprint 197 12.5.5.2 Regional footprint 198 12.5.5.3 Product type footprint 199 12.5.5.4 Application footprint 200 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 201 12.6.1 PROGRESSIVE COMPANIES 201 12.6.2 RESPONSIVE COMPANIES 201 12.6.3 DYNAMIC COMPANIES 201 12.6.4 STARTING BLOCKS 201 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 203 12.6.5.1 Detailed list of key startups/SMEs 203 12.6.5.2 Competitive benchmarking of key startups/SMEs 204 12.7 COMPANY VALUATION AND FINANCIAL METRICS 206 12.8 BRAND/SERVICE COMPARATIVE ANALYSIS 208 12.9 COMPETITIVE SCENARIO 209 12.9.1 PRODUCT/SERVICE LAUNCHES AND ENHANCEMENTS 209 12.9.2 DEALS 211 12.9.3 EXPANSIONS 212 12.9.4 OTHER DEVELOPMENTS 213 13 COMPANY PROFILES 215 13.1 KEY PLAYERS 215 13.1.1 CANOPY GROWTH CORPORATION 215 13.1.1.1 Business overview 215 13.1.1.2 Products/Solutions/Services offered 216 13.1.1.3 Recent developments 218 13.1.1.3.1 Product/Service launches 218 13.1.1.3.2 Deals 220 13.1.1.3.3 Expansions 221 13.1.1.4 MnM view 221 13.1.1.4.1 Right to win 221 13.1.1.4.2 Strategic choices 221 13.1.1.4.3 Weaknesses and competitive threats 222 13.1.2 CURALEAF, INC. 223 13.1.2.1 Business overview 223 13.1.2.2 Products/Solutions/Services offered 224 13.1.2.3 Recent developments 225 13.1.2.3.1 Product/Service launches 225 13.1.2.3.2 Deals 226 13.1.2.3.3 Expansions 227 13.1.2.3.4 Other developments 228 13.1.2.4 MnM view 229 13.1.2.4.1 Right to win 229 13.1.2.4.2 Strategic choices 229 13.1.2.4.3 Weaknesses and competitive threats 229 13.1.3 GREEN THUMB INDUSTRIES 230 13.1.3.1 Business overview 230 13.1.3.2 Products/Solutions/Services offered 231 13.1.3.3 Recent developments 232 13.1.3.3.1 Product/Service launches 232 13.1.3.3.2 Deals 233 13.1.3.3.3 Expansions 234 13.1.3.4 MnM view 234 13.1.3.4.1 Right to win 234 13.1.3.4.2 Strategic choices 234 13.1.3.4.3 Weaknesses and competitive threats 235 13.1.4 TILRAY BRANDS, INC. 236 13.1.4.1 Business overview 236 13.1.4.2 Products/Solutions/Services offered 237 13.1.4.3 Recent developments 239 13.1.4.3.1 Product/Service launches 239 13.1.4.3.2 Deals 241 13.1.4.3.3 Other developments 241 13.1.4.4 MnM view 242 13.1.4.4.1 Right to win 242 13.1.4.4.2 Strategic choices 242 13.1.4.4.3 Weaknesses and competitive threats 242 13.1.5 TRULIEVE 243 13.1.5.1 Business overview 243 13.1.5.2 Products/Solutions/Services offered 244 13.1.5.3 Recent developments 244 13.1.5.3.1 Product/Service launches 244 13.1.5.3.2 Deals 245 13.1.5.4 MnM view 246 13.1.5.4.1 Right to win 246 13.1.5.4.2 Strategic choices 247 13.1.5.4.3 Weaknesses and competitive threats 247 13.1.6 CRESCO LABS 248 13.1.6.1 Business overview 248 13.1.6.2 Products/Solutions/Services offered 249 13.1.6.3 Recent developments 250 13.1.6.3.1 Product/Service launches 250 13.1.6.3.2 Deals 250 13.1.6.3.3 Other developments 251 13.1.6.4 MnM view 251 13.1.7 AURORA CANNABIS INC. 252 13.1.7.1 Business overview 252 13.1.7.2 Products/Solutions/Services offered 253 13.1.7.3 Recent developments 254 13.1.7.3.1 Product/Service Launches 254 13.1.7.3.2 Deals 256 13.1.7.3.3 Expansions 257 13.1.7.4 MnM view 258 13.1.8 ORGANIGRAM GLOBAL 259 13.1.8.1 Business overview 259 13.1.8.2 Products/Solutions/Services offered 260 13.1.8.3 Recent developments 261 13.1.8.3.1 Product/Service Launches 261 13.1.8.3.2 Deals 262 13.1.8.3.3 Other developments 264 13.1.8.4 MnM view 264 13.1.9 TERRASCEND 265 13.1.9.1 Business overview 265 13.1.9.2 Products/Solutions/Services offered 266 13.1.9.3 Recent developments 267 13.1.9.3.1 Deals 267 13.1.9.3.2 Expansions 268 13.1.9.4 MnM view 269 13.1.10 BLÜM HOLDINGS INC. 270 13.1.10.1 Business overview 270 13.1.10.2 Products/Solutions/Services offered 271 13.1.10.3 Recent developments 271 13.1.10.3.1 Deals 271 13.1.10.3.2 Other developments 272 13.1.10.4 MnM view 273 13.1.11 VILLAGE FARMS INTERNATIONAL INC. 274 13.1.11.1 Business overview 274 13.1.11.2 Products/Solutions/Services offered 275 13.1.11.3 Recent developments 276 13.1.11.3.1 Product/Service launches 276 13.1.11.3.2 Deals 277 13.1.11.3.3 Other developments 278 13.1.11.4 MnM view 278 13.1.12 VERANO 279 13.1.12.1 Business overview 279 13.1.12.2 Products/Solutions/Services offered 280 13.1.12.3 Recent developments 281 13.1.12.3.1 Product/Service launches 281 13.1.12.3.2 Deals 282 13.1.12.3.3 Expansions 283 13.1.12.4 MnM view 284 13.1.13 THE CRONOS GROUP 285 13.1.13.1 Business overview 285 13.1.13.2 Products/Solutions/Services offered 286 13.1.13.3 Recent developments 287 13.1.13.3.1 Product/Service launches 287 13.1.13.3.2 Deals 289 13.1.13.3.3 Other developments 289 13.1.13.4 MnM view 290 13.1.14 MEDICAL MARIJUANA, INC. 291 13.1.14.1 Business overview 291 13.1.14.2 Products/Solutions/Services offered 292 13.1.14.3 Recent developments 293 13.1.14.3.1 Product/Service launches 293 13.1.14.3.2 Deals 294 13.1.14.4 MnM view 294 13.1.15 MEDIPHARM LABS 295 13.1.15.1 Business overview 295 13.1.15.2 Products/Solutions/Services offered 296 13.1.15.3 Recent developments 298 13.1.15.3.1 Product/Service launches 298 13.1.15.3.2 Deals 298 13.1.15.4 MnM view 299 13.2 OTHER PLAYERS 300 13.2.1 CANNBIT 300 13.2.1.1 Business overview 300 13.2.1.2 Products/Solutions/Services offered 301 13.2.1.3 MnM view 302 13.2.2 MARICANN INC. 303 13.2.2.1 Business overview 303 13.2.2.2 Products/Solutions/Services offered 303 13.2.2.3 MnM view 304 13.2.3 CANNABLISS ORGANIC LLC. 305 13.2.3.1 Business overview 305 13.2.3.2 Products/Solutions/Services offered 305 13.2.3.3 MnM view 305 13.2.4 CONNECTED CANNABIS CO. 306 13.2.4.1 Business overview 306 13.2.4.2 Products/Solutions/Services offered 306 13.2.4.3 MnM view 308 13.2.5 TOWER THREE LLC 309 13.2.5.1 Business overview 309 13.2.5.2 Products/Solutions/Services offered 309 13.2.5.3 MnM view 309 13.2.6 SATIPHARM 310 13.2.7 JUSTICE CANNABIS CO. 311 13.2.8 HERITAGE CANNABIS 312 13.2.9 SOMAÍ PHARMACEUTICALS LTD. 312 13.2.10 HENRY’S ORIGINAL 313 14 ADJACENT & RELATED MARKETS 314 14.1 INTRODUCTION 314 14.2 LIMITATIONS 314 14.3 INDUSTRIAL HEMP MARKET 314 14.3.1 MARKET DEFINITION 314 14.3.2 MARKET OVERVIEW 314 14.4 CANNABIS TESTING MARKET 316 14.4.1 MARKET DEFINITION 316 14.4.2 MARKET OVERVIEW 316 15 APPENDIX 318 15.1 DISCUSSION GUIDE 318 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 321 15.3 CUSTOMIZATION OPTIONS 323 15.4 RELATED REPORTS 323 15.5 AUTHOR DETAILS 324

圖表清單 List of Tables & Figures

TABLE 1 INCLUSIONS AND EXCLUSIONS 29 TABLE 2 USD EXCHANGE RATES CONSIDERED, 2020–2024 30 TABLE 3 CANNABIS MARKET SHARE SNAPSHOT, 2025 VS. 2030 (USD MILLION) 41 TABLE 4 INORGANIC GROWTH STRATEGIES ADOPTED BY KEY PLAYERS 63 TABLE 5 EXPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES, 2021–2024 (USD THOUSAND) 74 TABLE 6 EXPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES, 2020–2024 (KG) 74 TABLE 7 IMPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES, 2021–2024 (USD THOUSAND) 76 TABLE 8 IMPORT SCENARIO OF HS CODE 530210 FOR TOP 10 COUNTRIES, 2021–2024 (KG) 76 TABLE 9 AVERAGE SELLING PRICE TREND OF CANNABIS FLOWERS, BY KEY PLAYER, 2025 (USD/G) 82 TABLE 10 INDICATIVE SELLING PRICE TREND, BY SOURCE, 2025 (USD/KG) 82 TABLE 11 INDICATIVE SELLING PRICE TREND, BY REGION, 2025 (USD/KG) 83 TABLE 12 ROLE OF COMPANIES IN ECOSYSTEM 84 TABLE 13 PATENTS PERTAINING TO CANNABIS MARKET AND RELATED PATENTS, 2016–2024 87 TABLE 14 CANNABIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 91 TABLE 15 CANNABIS MARKET: TARIFF FOR HS CODE 530210, 2024 91 TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 20 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES 100 TABLE 22 EXPECTED IMPACT ON PRODUCTS UNDER RELEVANT HS CODES 102 TABLE 23 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: CANNABIS PRODUCTS 104 TABLE 24 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS 105 TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TEST TYPE (%) 109 TABLE 26 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES 109 TABLE 27 CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 113 TABLE 28 CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 113 TABLE 29 THC-DOMINANT CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 114 TABLE 30 THC-DOMINANT CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 115 TABLE 31 CBD-DOMINANT CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 116 TABLE 32 CBD-DOMINANT CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 116 TABLE 33 BALANCED THC & CBD CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 117 TABLE 34 BALANCED THC & CBD CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 117 TABLE 35 CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 119 TABLE 36 CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 120 TABLE 37 FLOWERS/BUDS: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 121 TABLE 38 FLOWERS/BUDS: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 122 TABLE 39 OILS/TINCTURES: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 123 TABLE 40 OILS/TINCTURES: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 41 EDIBLES: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 124 TABLE 42 EDIBLES: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 124 TABLE 43 TOPICALS: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 125 TABLE 44 TOPICALS: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 126 TABLE 45 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 127 TABLE 46 OTHER PRODUCT TYPES: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 127 TABLE 47 CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 129 TABLE 49 CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 130 TABLE 50 MEDICINAL USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 132 TABLE 51 MEDICINAL USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 132 TABLE 52 RECREATIONAL USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 134 TABLE 53 RECREATIONAL USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 134 TABLE 54 INDUSTRIAL USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 137 TABLE 55 INDUSTRIAL USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 137 TABLE 56 NUTRACEUTICAL & WELLNESS USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 138 TABLE 57 NUTRACEUTICAL & WELLNESS USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 138 TABLE 58 COSMETIC & PERSONAL CARE USE: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 139 TABLE 59 COSMETIC & PERSONAL CARE USE: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 140 TABLE 60 CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 142 TABLE 61 CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 142 TABLE 62 HEMP: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 144 TABLE 63 HEMP: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 144 TABLE 64 MARIJUANA: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 145 TABLE 65 MARIJUANA: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 146 TABLE 66 CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 149 TABLE 67 CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 149 TABLE 68 CANNABIS MARKET, BY REGION, 2020–2024 (TONS) 149 TABLE 69 CANNABIS MARKET, BY REGION, 2025–2030 (TONS) 150 TABLE 70 NORTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 151 TABLE 71 NORTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 152 TABLE 72 NORTH AMERICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 152 TABLE 73 NORTH AMERICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 152 TABLE 74 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 152 TABLE 75 NORTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 153 TABLE 76 NORTH AMERICA: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 153 TABLE 77 NORTH AMERICA: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 153 TABLE 78 NORTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 154 TABLE 79 NORTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 154 TABLE 80 US: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 155 TABLE 81 US: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 155 TABLE 82 CANADA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 156 TABLE 83 CANADA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 156 TABLE 84 MEXICO: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 157 TABLE 85 MEXICO: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 157 TABLE 86 EUROPE: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 159 TABLE 87 EUROPE: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 159 TABLE 88 EUROPE: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 159 TABLE 89 EUROPE: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 160 TABLE 90 EUROPE: CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 160 TABLE 91 EUROPE: CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 160 TABLE 92 EUROPE: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 160 TABLE 93 EUROPE: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 161 TABLE 94 EUROPE: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 161 TABLE 95 EUROPE: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 161 TABLE 96 GERMANY: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 162 TABLE 97 GERMANY: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 162 TABLE 98 UK: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 163 TABLE 99 UK: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 163 TABLE 100 FRANCE: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 164 TABLE 101 FRANCE: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 164 TABLE 102 SPAIN: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 165 TABLE 103 SPAIN: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 165 TABLE 104 ITALY: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 166 TABLE 105 ITALY: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 166 TABLE 106 REST OF EUROPE: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 167 TABLE 107 REST OF EUROPE: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 168 TABLE 108 ASIA PACIFIC: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 168 TABLE 109 ASIA PACIFIC: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 169 TABLE 110 ASIA PACIFIC: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 169 TABLE 111 ASIA PACIFIC: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 169 TABLE 112 ASIA PACIFIC: CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 169 TABLE 113 ASIA PACIFIC: CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 170 TABLE 114 ASIA PACIFIC: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 170 TABLE 115 ASIA PACIFIC: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 170 TABLE 116 ASIA PACIFIC: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 171 TABLE 117 ASIA PACIFIC: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 171 TABLE 118 CHINA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 172 TABLE 119 CHINA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 172 TABLE 120 INDIA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 173 TABLE 121 INDIA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 173 TABLE 122 JAPAN: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 174 TABLE 123 JAPAN: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 174 TABLE 124 AUSTRALIA & NEW ZEALAND: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 175 TABLE 125 AUSTRALIA & NEW ZEALAND: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 175 TABLE 126 THAILAND: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 176 TABLE 127 THAILAND: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 176 TABLE 128 REST OF ASIA PACIFIC: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 177 TABLE 129 REST OF ASIA PACIFIC: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 177 TABLE 130 SOUTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 178 TABLE 131 SOUTH AMERICA: CANNABIS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 178 TABLE 132 SOUTH AMERICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 178 TABLE 133 SOUTH AMERICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 178 TABLE 134 SOUTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 179 TABLE 135 SOUTH AMERICA: CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 179 TABLE 136 SOUTH AMERICA: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 179 TABLE 137 SOUTH AMERICA: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 179 TABLE 138 SOUTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 180 TABLE 139 SOUTH AMERICA: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 180 TABLE 140 BRAZIL: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 181 TABLE 141 BRAZIL: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 181 TABLE 142 ARGENTINA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 182 TABLE 143 ARGENTINA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 182 TABLE 144 REST OF SOUTH AMERICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 183 TABLE 145 REST OF SOUTH AMERICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 183 TABLE 146 REST OF THE WORLD: CANNABIS MARKET, BY REGION, 2020–2024 (USD MILLION) 184 TABLE 147 REST OF THE WORLD: CANNABIS MARKET, BY REGION, 2025–2030 (USD MILLION) 184 TABLE 148 REST OF THE WORLD: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 184 TABLE 149 REST OF THE WORLD: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 184 TABLE 150 REST OF THE WORLD: CANNABIS MARKET, BY COMPOUND TYPE, 2020–2024 (USD MILLION) 184 TABLE 151 REST OF THE WORLD: CANNABIS MARKET, BY COMPOUND TYPE, 2025–2030 (USD MILLION) 185 TABLE 152 REST OF THE WORLD: CANNABIS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 185 TABLE 153 REST OF THE WORLD: CANNABIS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 185 TABLE 154 REST OF THE WORLD: CANNABIS MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION) 186 TABLE 155 REST OF THE WORLD: CANNABIS MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 186 TABLE 156 MIDDLE EAST: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 187 TABLE 157 MIDDLE EAST: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 187 TABLE 158 AFRICA: CANNABIS MARKET, BY SOURCE, 2020–2024 (USD MILLION) 188 TABLE 159 AFRICA: CANNABIS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 188 TABLE 160 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CANNABIS MARKET 190 TABLE 161 CANNABIS MARKET: DEGREE OF COMPETITION 193 TABLE 162 CANNABIS MARKET: REGIONAL FOOTPRINT 198 TABLE 163 CANNABIS MARKET: PRODUCT TYPE FOOTPRINT 199 TABLE 164 CANNABIS MARKET: APPLICATION FOOTPRINT 200 TABLE 165 CANNABIS MARKET: KEY STARTUPS/SMES 203 TABLE 166 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 (1/2) 204 TABLE 167 CANNABIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024 (2/2) 205 TABLE 168 CANNABIS MARKET: PRODUCT/SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2021–MAY 2025 209 TABLE 169 CANNABIS MARKET: DEALS, JANUARY 2021– MAY 2025 211 TABLE 170 CANNABIS MARKET: EXPANSIONS, JANUARY 2021–MAY 2025 212 TABLE 171 CANNABIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021– MAY 2025 213 TABLE 172 CANOPY GROWTH CORPORATION: COMPANY OVERVIEW 215 TABLE 173 CANOPY GROWTH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216 TABLE 174 CANOPY GROWTH CORPORATION: PRODUCT/SERVICE LAUNCHES 218 TABLE 175 CANOPY GROWTH CORPORATION: DEALS 220 TABLE 176 CANOPY GROWTH CORPORATION: EXPANSIONS 221 TABLE 177 CURALEAF, INC.: COMPANY OVERVIEW 223 TABLE 178 CURALEAF, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 224 TABLE 179 CURALEAF, INC.: PRODUCT/SERVICE LAUNCHES 225 TABLE 180 CURALEAF, INC.: DEALS 226 TABLE 181 CURALEAF, INC.: EXPANSIONS 227 TABLE 182 CURALEAF, INC.: OTHER DEVELOPMENTS 228 TABLE 183 GREEN THUMB INDUSTRIES: COMPANY OVERVIEW 230 TABLE 184 GREEN THUMB INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 231 TABLE 185 GREEN THUMB INDUSTRIES: PRODUCT/SERVICE LAUNCHES 232 TABLE 186 GREEN THUMB INDUSTRIES: DEALS 233 TABLE 187 GREEN THUMB INDUSTRIES: EXPANSIONS 234 TABLE 188 TILRAY BRANDS, INC.: COMPANY OVERVIEW 236 TABLE 189 TILRAY BRANDS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 237 TABLE 190 TILRAY BRANDS, INC.: PRODUCT/SERVICE LAUNCHES 239 TABLE 191 TILRAY BRANDS, INC.: DEALS 241 TABLE 192 TILRAY BRANDS, INC.: OTHER DEVELOPMENTS 241 TABLE 193 TRULIEVE: COMPANY OVERVIEW 243 TABLE 194 TRULIEVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244 TABLE 195 TRULIEVE: PRODUCT/SERVICE LAUNCHES 244 TABLE 196 TRULIEVE: DEALS 245 TABLE 197 CRESCO LABS: COMPANY OVERVIEW 248 TABLE 198 CRESCO LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249 TABLE 199 CRESCO LABS: PRODUCT/SERVICE LAUNCHES 250 TABLE 200 CRESCO LABS: DEALS 250 TABLE 201 CRESCO LABS: OTHER DEVELOPMENTS 251 TABLE 202 AURORA CANNABIS INC.: COMPANY OVERVIEW 252 TABLE 203 AURORA CANNABIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 253 TABLE 204 AURORA CANNABIS INC.: PRODUCT/SERVICE LAUNCHES 254 TABLE 205 AURORA CANNABIS INC.: DEALS 256 TABLE 206 AURORA CANNABIS INC.: EXPANSIONS 257 TABLE 207 ORGANIGRAM GLOBAL: COMPANY OVERVIEW 259 TABLE 208 ORGANIGRAM GLOBAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260 TABLE 209 ORGANIGRAM GLOBAL: PRODUCT/SERVICE LAUNCHES 261 TABLE 210 ORGANIGRAM GLOBAL: DEALS 262 TABLE 211 ORGANIGRAM GLOBAL: OTHER DEVELOPMENTS 264 TABLE 212 TERRASCEND: COMPANY OVERVIEW 265 TABLE 213 TERRASCEND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 266 TABLE 214 TERRASCEND: DEALS 267 TABLE 215 TERRASCEND: EXPANSIONS 268 TABLE 216 BLÜM HOLDINGS INC.: COMPANY OVERVIEW 270 TABLE 217 BLÜM HOLDINGS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 271 TABLE 218 BLÜM HOLDINGS INC.: DEALS 271 TABLE 219 BLÜM HOLDINGS INC.: OTHER DEVELOPMENTS 272 TABLE 220 VILLAGE FARMS INTERNATIONAL INC.: COMPANY OVERVIEW 274 TABLE 221 VILLAGE FARMS INTERNATIONAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275 TABLE 222 VILLAGE FARMS INTERNATIONAL INC.: PRODUCT/SERVICE LAUNCHES 276 TABLE 223 VILLAGE FARMS INTERNATIONAL INC.: DEALS 277 TABLE 224 VILLAGE FARMS INTERNATIONAL INC.: OTHER DEVELOPMENTS 278 TABLE 225 VERANO: COMPANY OVERVIEW 279 TABLE 226 VERANO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 280 TABLE 227 VERANO: PRODUCT/SERVICE LAUNCHES 281 TABLE 228 VERANO: DEALS 282 TABLE 229 VERANO: EXPANSIONS 283 TABLE 230 THE CRONOS GROUP: COMPANY OVERVIEW 285 TABLE 231 THE CRONOS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 286 TABLE 232 THE CRONOS GROUP: PRODUCT/SERVICE LAUNCHES 287 TABLE 233 THE CRONOS GROUP: DEALS 289 TABLE 234 THE CRONOS GROUP: OTHER DEVELOPMENTS 289 TABLE 235 MEDICAL MARIJUANA, INC.: COMPANY OVERVIEW 291 TABLE 236 MEDICAL MARIJUANA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292 TABLE 237 MEDICAL MARIJUANA, INC.: PRODUCT/SERVICE LAUNCHES 293 TABLE 238 MEDICAL MARIJUANA, INC.: DEALS 294 TABLE 239 MEDIPHARM LABS: COMPANY OVERVIEW 295 TABLE 240 MEDIPHARM LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 296 TABLE 241 MEDIPHARM LABS: PRODUCT/SERVICE LAUNCHES 298 TABLE 242 MEDIPHARM LABS: DEALS 298 TABLE 243 CANNBIT: COMPANY OVERVIEW 300 TABLE 244 CANNBIT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 301 TABLE 245 MARICANN INC.: COMPANY OVERVIEW 303 TABLE 246 MARICANN INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 303 TABLE 247 CANNABLISS ORGANIC LLC.: COMPANY OVERVIEW 305 TABLE 248 CANNABLISS ORGANIC LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 305 TABLE 249 CONNECTED CANNABIS CO.: COMPANY OVERVIEW 306 TABLE 250 CONNECTED CANNABIS CO.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 306 TABLE 251 TOWER THREE LLC: COMPANY OVERVIEW 309 TABLE 252 TOWER THREE LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 309 TABLE 253 ADJACENT MARKETS 314 TABLE 254 INDUSTRIAL HEMP MARKET, BY TYPE, 2019–2023 (USD MILLION) 315 TABLE 255 INDUSTRIAL HEMP MARKET, BY TYPE, 2024–2029 (USD MILLION) 315 TABLE 256 INDUSTRIAL HEMP MARKET, BY TYPE, 2019–2023 (KT) 315 TABLE 257 INDUSTRIAL HEMP MARKET, BY TYPE, 2024–2029 (KT) 316 TABLE 258 CANNABIS TESTING MARKET, BY PRODUCT & SOFTWARE, 2022–2029 (USD MILLION) 317 FIGURE 1 CANNABIS MARKET: RESEARCH DESIGN 32 FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE)—COLLECTIVE REVENUE OF ALL PRODUCTS 36 FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (DEMAND SIDE) 36 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 (TOP-DOWN) 37 FIGURE 5 CANNABIS MARKET: DATA TRIANGULATION 38 FIGURE 6 THC-DOMINANT CANNABIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD 42 FIGURE 7 FLOWERS/BUDS TO HOLD LARGEST MARKET SHARE 43 FIGURE 8 RECREATIONAL USE APPLICATION TO ACCOUNT FOR LARGER MARKET SHARE DURING FORECAST PERIOD 43 FIGURE 9 MARIJUANA TO DOMINATE CANNABIS MARKET, BY SOURCE, DURING FORECAST PERIOD 44 FIGURE 10 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 45 FIGURE 11 GROWING MEDICINAL APPLICATIONS AND INCREASING LEGALIZATION OF CANNABIS CREATE OPPORTUNITIES 46 FIGURE 12 US TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 47 FIGURE 13 US AND THC-DOMINANT SEGMENT TO ACCOUNT FOR SIGNIFICANT SHARES IN 2024 47 FIGURE 14 MARIJUANA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 48 FIGURE 15 THC-DOMINANT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 49 FIGURE 16 RECREATIONAL USE SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 49 FIGURE 17 FLOWERS/BUDS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 50 FIGURE 18 LEADING CANNABIS-PRODUCING COUNTRIES, 2023 (USD MILLION) 52 FIGURE 19 SURVEY-INDICATED ANXIETY LEVELS AMONG US ADULTS (%) 52 FIGURE 20 TOP ANXIETY TRIGGERS AMONG US ADULTS IN 2024 53 FIGURE 21 CANNABIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54 FIGURE 22 EUROPE: USERS ENTERING CANNABIS TREATMENT, 2023 55 FIGURE 23 GLOBAL REGULATORY OVERVIEW INDICATING LEGALITY OF CANNABIS, 2024 57 FIGURE 24 ADOPTION OF GEN AI IN CANNABIS MARKET 67 FIGURE 25 CANNABIS MARKET: SUPPLY CHAIN ANALYSIS 71 FIGURE 26 CANNABIS MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 27 EXPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES, 2021–2024 (USD THOUSAND) 73 FIGURE 28 IMPORT DATA FOR HS CODE 530210 FOR TOP 10 COUNTRIES, 2021–2024 (USD THOUSAND) 75 FIGURE 29 CANNABIS MARKET: ECOSYSTEM 84 FIGURE 30 CANNABIS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85 FIGURE 31 PATENTS APPLIED AND GRANTED, 2015–2024 86 FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR CANNABIS AND RELATED MARKETS, 2015–2024 87 FIGURE 33 CANNABIS MARKET: PORTER’S FIVE FORCES ANALYSIS 106 FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 108 FIGURE 35 KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES 109 FIGURE 36 CANNABIS MARKET: INVESTMENT AND FUNDING SCENARIO, 2021–2025 111 FIGURE 37 CANNABIS MARKET, BY COMPOUND TYPE, 2025 VS. 2030 (USD MILLION) 113 FIGURE 38 CANNABIS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 119 FIGURE 39 CANNABIS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 129 FIGURE 40 CANNABIS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 142 FIGURE 41 GERMANY TO RECORD FASTEST GROWTH FROM 2025 TO 2030 148 FIGURE 42 NORTH AMERICA: MARKET SNAPSHOT 151 FIGURE 43 EUROPE: MARKET SNAPSHOT 158 FIGURE 44 REVENUE ANALYSIS FOR KEY PLAYERS, 2019–2023 192 FIGURE 45 CANNABIS MARKET SHARE ANALYSIS, 2024 193 FIGURE 46 CANNABIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 196 FIGURE 47 CANNABIS MARKET: COMPANY FOOTPRINT 197 FIGURE 48 CANNABIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 202 FIGURE 49 COMPANY VALUATION OF KEY VENDORS 206 FIGURE 50 FINANCIAL METRICS OF KEY VENDORS 206 FIGURE 51 YEAR-TO-DATE PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 207 FIGURE 52 CANNABIS MARKET: BRAND/SERVICE COMPARISON 208 FIGURE 53 CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT 216 FIGURE 54 CURALEAF, INC.: COMPANY SNAPSHOT 223 FIGURE 55 GREEN THUMB INDUSTRIES: COMPANY SNAPSHOT 230 FIGURE 56 TILRAY BRANDS, INC.: COMPANY SNAPSHOT 237 FIGURE 57 TRULIEVE: COMPANY SNAPSHOT 243 FIGURE 58 CRESCO LABS: COMPANY SNAPSHOT 248 FIGURE 59 AURORA CANNABIS INC.: COMPANY SNAPSHOT 252 FIGURE 60 ORGANIGRAM GLOBAL: COMPANY SNAPSHOT 260 FIGURE 61 TERRASCEND: COMPANY SNAPSHOT 265 FIGURE 62 BLÜM HOLDINGS INC.: COMPANY SNAPSHOT 270 FIGURE 63 VILLAGE FARMS INTERNATIONAL INC.: COMPANY SNAPSHOT 275 FIGURE 64 VERANO: COMPANY SNAPSHOT 280 FIGURE 65 THE CRONOS GROUP: COMPANY SNAPSHOT 286 FIGURE 66 MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT 291 FIGURE 67 MEDIPHARM LABS: COMPANY SNAPSHOT 296 FIGURE 68 CANNBIT: COMPANY SNAPSHOT 301

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

授權報價

報告摘要

同分類最新報告（食品與飲料）